Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape.

OBJECTIVES: To summarise the epidemiology, risk and prognostic factors, and treatment landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). METHODS: Targeted and systematic literature reviews were conducted to characterise the epidemiology and treatment landscape associated with RA-ILD, respectively. MEDLINE®, Embase, and CENTRAL were searched via OvidSP in March 2019 and December 2018. The results were narratively summarised. RESULTS: A total of 24 and 20 publications were captured through targeted and systematic literature review, respectively. No randomised controlled trials were identified; publications were observational cohort studies, cross-sectional, or case-control. Unadjusted incidence of interstitial lung disease (ILD) ranged from 1.3/1,000 person-years for interstitial pneumonia-type ILD to 5.0/1,000 person-years for 'probable or definite ILD'. Prevalence of ILD ranged from 1.8% to 67% (median: 24.9%) and varied with case definition and sample size. Few publications identified the same risk and prognostic factors; age, male sex, duration of disease, and antibodies to cyclic citrullinated peptides were the most frequently reported risk factors for development of RA-ILD, and age was the most common predictor of mortality. Despite identification of a variety of pharmacotherapeutic interventions, assessment of the comparative efficacy and safety of the available treatments were difficult due to heterogenous reporting of outcomes and small sample size. CONCLUSIONS: A wide range of estimates were identified for incidence and prevalence of RA-ILD. Further, there was no consensus on risk and prognostic factors. Sufficiently powered clinical trials are needed to confirm the findings of the observational studies with respect to efficacy and safety of current treatments.

Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder.

OBJECTIVES: Though the pathophysiology underlying schizophrenia (SCZ) and bipolar disorder (BD) is not fully understood, immune function may be dysregulated, with microglia, the brain's resident immune cells, implicated in this process. Signalling between the neuronal chemokine fractalkine (CX3CL1) and its microglial receptor CX3CR1 facilitates neuron-microglia interactions, influencing microglial activation and synaptic function. As such, alterations in fractalkine signalling may contribute to immune and synaptic alterations observed in SCZ and BD. METHODS: Protein and mRNA expression of fractalkine, CX3CR1, and a disintegrin and metalloproteinase 10 (ADAM10), a sheddase that cleaves fractalkine, were quantified in post-mortem frontal cortex from individuals with SCZ (n = 35), BD (n = 34), and matched controls (n = 35) using immunoblotting and droplet digital PCR. In addition, the relationship between fractalkine pathway members and levels of the pre-synaptic protein SNAP-25 was examined. RESULTS: Fractalkine protein levels were significantly lower in SCZ relative to controls. Expression of members of the fractalkine signalling pathway was unchanged in BD. CX3CR1 protein levels were significantly correlated with SNAP-25 levels. CONCLUSIONS: The observed deficit in fractalkine protein levels in SCZ is consistent with impaired neuron-microglia crosstalk in this disorder. Furthermore, our data are suggestive of an aberrant association between microglial function and synaptic density in SCZ.

Enhancement of the destruction of propane in a low-temperature plasma by the addition of unsaturated hydrocarbons: experiment and modeling.

The oxidative destruction of propane at low temperature ( approximately 150 degrees C) in a nonthermal, atmospheric pressure plasma can be significantly enhanced without the use of a catalyst by the simple addition of an unsaturated alkene. An enhancement in the destruction of propane of up to 45% can be achieved by the addition of propene. Propene acts as a supply of OH radicals, which accelerate the breakdown of the propane. Ethene also enhances the destruction of propane but to a more limited extent. The experimental results are interpreted by chemical modeling, which is used to elucidate the reaction mechanisms.

The destruction of atmospheric pressure propane and propene using a surface discharge plasma reactor.

Surface discharge plasma reactors (SDRs) have been shown to be effective in removing a wide range of pollutants. In this study, the effectiveness of a SDR for the removal of propane and propene from an atmospheric pressure air stream was investigated. For an input energy of 100 J L-1, the conversions were found to be 16% and 68% for propane and propene, respectively. The total carbon recovery was found to increase with increasing specific input energy (SIE) for both hydrocarbons. FTIR analysis showed that CO and CO2 are the major end-products, and GC-MS identified formic acid as a significant byproduct. The effect of initial propane concentration was also investigated. The reaction chemistry involved in the oxidative plasma conversion of propane and propene is discussed.